search
Back to results

Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease (POPI)

Primary Purpose

Pelvic Inflammatory Disease, Chlamydia Infections

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Screening for chlamydia using self-taken vaginal swabs
Sponsored by
St George's, University of London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pelvic Inflammatory Disease focused on measuring Pelvic inflammatory disease, Chlamydia trachomatis, Screening

Eligibility Criteria

16 Years - 27 Years (Child, Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Sexually active Exclusion Criteria: Never been sexually active Tested for chlamydia in past 3 months and no new sexual partner since then Pregnant

Sites / Locations

  • St George's Hospital Medical School

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Deferred screening control group

Arm Description

Samples from women in the control group were stored and tested at the end of the trial

Outcomes

Primary Outcome Measures

Primary outcome measure in the complete cohort: Incidence of clinical PID over 12 months in intervention and control groups.

Secondary Outcome Measures

Secondary outcome measures after 12 months in women with chlamydial infection at baseline:
Control group (untreated):
Incidence of PID.
Percentage with spontaneous clearance of genital infection.
Relative risk of PID in women with and without BV
3. Intervention group (treated): Reinfection rate.

Full Information

First Posted
June 21, 2005
Last Updated
November 21, 2014
Sponsor
St George's, University of London
search

1. Study Identification

Unique Protocol Identification Number
NCT00115388
Brief Title
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
Acronym
POPI
Official Title
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
Study Type
Interventional

2. Study Status

Record Verification Date
November 2014
Overall Recruitment Status
Completed
Study Start Date
September 2004 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
December 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
St George's, University of London

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Chlamydial infection is a common, sexually transmitted disease which women can have without knowing. Untreated, it can lead to an infection of the womb and fallopian tubes called pelvic inflammatory disease (PID), which can cause infertility. There has been only one trial of chlamydia screening and this was in American women in 1992 and used outdated tests. We now need to see if screening using modern tests and self-taken swabs works in a high risk, young, multiethnic female population in the United Kingdom (UK). The study is a randomised trial. It will involve asking women students in college bars to complete confidential questionnaires on sexual health and to provide self-administered vaginal swabs. We have successfully done this in a small pilot study. Participants will be told that the tests are for research purposes only and that if they think they may have been at risk of a sexually transmitted infection they should get checked at a clinic. If the trial shows that chlamydia screening using these new methods prevents PID, extending this community-based intervention nationwide could improve women's reproductive health and wellbeing and might prevent some women from becoming infertile
Detailed Description
Background: Pelvic inflammatory disease (PID) is common and can lead to infertility, ectopic pregnancy or chronic pelvic pain. Objectives: To see if screening and treatment of chlamydial infection reduces the incidence of PID over 12 months, and to investigate the natural history of chlamydial infection and the role of bacterial vaginosis (BV) in the development of chlamydia associated PID. Design: Randomised trial over one year Setting: Common rooms, bars and lecture theatres at universities and colleges in London, UK. Participants: 2500 sexually active female students aged <28 years will be asked to complete a questionnaire on sexual health and to provide a self-administered vaginal swab and smear with follow up after a year. Intervention: Following randomisation, vaginal swabs from intervention women will be tested for chlamydia by PCR and those infected referred for treatment. Vaginal swabs from control women will be stored and analysed after a year. Vaginal smears will be Gram stained and analysed for BV. Main outcome measure: Incidence of clinical PID over 12 months in intervention and control groups. Possible cases of PID will be identified from questionnaires and record searches. Confirmation of the diagnosis will be done by detailed review of medical records by two independent researchers blind to whether the woman is in the intervention or control group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Inflammatory Disease, Chlamydia Infections
Keywords
Pelvic inflammatory disease, Chlamydia trachomatis, Screening

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
2531 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Deferred screening control group
Arm Type
Other
Arm Description
Samples from women in the control group were stored and tested at the end of the trial
Intervention Type
Procedure
Intervention Name(s)
Screening for chlamydia using self-taken vaginal swabs
Intervention Description
Women in the intervention group will be tested for chlamydia and those found to be infected will be referred for treatment and partner notification
Primary Outcome Measure Information:
Title
Primary outcome measure in the complete cohort: Incidence of clinical PID over 12 months in intervention and control groups.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Secondary outcome measures after 12 months in women with chlamydial infection at baseline:
Time Frame
12 months
Title
Control group (untreated):
Time Frame
12 months
Title
Incidence of PID.
Time Frame
12 months
Title
Percentage with spontaneous clearance of genital infection.
Time Frame
12 months
Title
Relative risk of PID in women with and without BV
Time Frame
12 months
Title
3. Intervention group (treated): Reinfection rate.
Time Frame
1-3 years

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
27 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Sexually active Exclusion Criteria: Never been sexually active Tested for chlamydia in past 3 months and no new sexual partner since then Pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pippa Oakeshott, MD FRCP
Organizational Affiliation
St George's, University of London
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Phillip Hay, FRCP
Organizational Affiliation
St George's, University of London
Official's Role
Study Chair
Facility Information:
Facility Name
St George's Hospital Medical School
City
London
ZIP/Postal Code
Sw17 ORE
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
26082320
Citation
Hay PE, Kerry SR, Normansell R, Horner PJ, Reid F, Kerry SM, Prime K, Williams E, Simms I, Aghaizu A, Jensen J, Oakeshott P. Which sexually active young female students are most at risk of pelvic inflammatory disease? A prospective study. Sex Transm Infect. 2016 Feb;92(1):63-6. doi: 10.1136/sextrans-2015-052063. Epub 2015 Jun 16.
Results Reference
derived
PubMed Identifier
20378636
Citation
Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, Simms I, Hay P. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010 Apr 8;340:c1642. doi: 10.1136/bmj.c1642.
Results Reference
derived
PubMed Identifier
19077198
Citation
Oakeshott P, Kerry S, Atherton H, Aghaizu A, Hay S, Taylor-Robinson D, Simms I, Hay P. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Trials. 2008 Dec 10;9:73. doi: 10.1186/1745-6215-9-73.
Results Reference
derived
PubMed Identifier
18053199
Citation
Atherton H, Banks D, Harbit R, Long L, Chadd F, Hay P, Kerry S, Simms I, Oakeshott P. Recruitment of young women to a trial of chlamydia screening - as easy as it sounds? Trials. 2007 Dec 4;8:41. doi: 10.1186/1745-6215-8-41.
Results Reference
derived

Learn more about this trial

Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease

We'll reach out to this number within 24 hrs